Rating History for Xeris Pharmaceuticals (XERS) by H.C. Wainwright
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 8/12/2025 | Brandon Folkes | New Coverage | Buy (N/A) |
10.00 (N/A) |
7.20 (8.28) |
15% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 8/12/2025 | Brandon Folkes | New Coverage | Buy (N/A) |
10.00 (N/A) |
7.20 (8.28) |
15% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||